Association between inflammatory markers and non-alcoholic fatty liver disease in obese children

Association between inflammatory markers and non-alcoholic fatty liver disease in obese children

BackgroundGiven the high prevalence of non-alcoholic fatty liver disease (NAFLD) in obese children, non-invasive markers of disease to date are still limited and worth exploring.ObjectiveThis study aimed to evaluate the association between inflammatory markers and NAFLD in obese children.MethodsWe p...

Full description

Bibliographic Details
Main Authors:	Yamei Duan, Jiayou Luo, Xiongfeng Pan, Jia Wei, Xiang Xiao, Jingya Li, Miyang Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Public Health
Subjects:	inflammatory markers cytokines non-alcoholic fatty liver disease association obesity children
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2022.991393/full

Similar Items

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

Pro-Inflammatory Adipokine and Cytokine Profiles in the Saliva of Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)—A Pilot Study
by: Beata Zyśk, et al.
Published: (2023-02-01)

Cytokines and inflammatory markers in nonalcoholic fatty liver disease: A narrative review
by: Sujal Patel, et al.
Published: (2023-01-01)

An evidence review of the association of immune and inflammatory markers with obesity-related eating behaviors
by: Ying Meng, et al.
Published: (2022-07-01)

Hepatocellular carcinoma and non-alcoholic fatty liver disease: a dangerous liaison
by: R. Nevola, et al.
Published: (2019-05-01)

Non-Alcoholic Fatty Liver Disease in Cardiac Patients with Overweight and Obesity
by: I. V. Logacheva, et al.
Published: (2019-01-01)

Chemokines in Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis
by: Xiongfeng Pan, et al.
Published: (2020-09-01)

Gender perspective on the association between liver enzyme markers and non-alcoholic fatty liver disease: insights from the general population
by: Jiajun Qiu, et al.
Published: (2023-12-01)

Comparative analysis of preventive role of different probiotics and prebiotics against the markers of liver damage, oxidative stress markers and inflammatory markers in the non-alcoholic fatty liver disease induced rats
by: Tayyab Shahzad, et al.
Published: (2022-12-01)

The association between the dietary inflammatory index (DII) and some serum oxidative stress markers in Non-Alcoholic fatty liver disease: Case- control
by: Fateme Moradi, et al.
Published: (2022-01-01)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
by: Maamon Basheer, et al.
Published: (2023-04-01)

Non-Alcoholic Fatty Liver Disease (NAFLD) in Obesity
by: Rushad Patell, et al.
Published: (2014-01-01)

A Balanced Dietary Ratio of n-6:n-3 Polyunsaturated Fatty Acids Exerts an Effect on Total Fatty Acid Profile in RBCs and Inflammatory Markers in Subjects with Obesity
by: Karina Gonzalez-Becerra, et al.
Published: (2023-08-01)

Fatty alcohols /
by: 271542 Wilson, Glenn R.

Non-alcoholic fatty liver disease associated with greater herpes zoster risk than alcoholic fatty liver disease
by: Cheng-Wei Yu, et al.
Published: (2023-12-01)

Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity
by: Carolina Jimenez-Rivera, et al.
Published: (2017-04-01)

Crosstalk between Oxidative Stress and Inflammatory Liver Injury in the Pathogenesis of Alcoholic Liver Disease
by: Yoon Mee Yang, et al.
Published: (2022-01-01)

Dietary inflammatory index (DII) is correlated with the incidence of non-alcoholic fatty liver disease (NAFLD): Fasa PERSIAN cohort study
by: Adib Valibeygi, et al.
Published: (2023-07-01)

Comparison of long‐term prognosis between non‐obese and obese patients with non‐alcoholic fatty liver disease
by: Michihiro Iwaki, et al.
Published: (2022-10-01)

COMPLICATIONS OF ALCOHOLIC LIVER DISEASE AND DIAGNOSTIC MARKERS
by: Milena Ilić, et al.
Published: (2011-12-01)

Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different
by: Stephen D. H. Malnick, et al.
Published: (2022-12-01)

Production of fatty alcohols from fatty acids /
by: 394629 Voeste, Theodor, et al.

Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children
by: Jiayou Luo, et al.
Published: (2024-04-01)

A pilot study of the associations between inflammatory markers and the presence of „deficit syndrome” in schizophrenia patients
by: A. Michalczyk, et al.
Published: (2022-06-01)

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
by: Luo Y, et al.
Published: (2019-12-01)

Evaluation of the effect of phytosomal curcuminoids on oxidative stress and inflammatory markers in NAFLD: A randomized double-blind placebo-controlled trial
by: Seyed Ali Hosseinian, et al.
Published: (2022-09-01)

Features of the State of Internal Organs and the Structure of Comorbidity in Deceased Persons With Alcoholic Liver Cirrhosis, Non-alcoholic Fatty Liver Disease at the Cirrhosis Stage and Alcoholic Liver Cirrhosis Associated With Insulin Resistance and Obesity
by: N. Matkovska
Published: (2020-06-01)

Salidroside-Mitigated Inflammatory Injury of Hepatocytes with Non-Alcoholic Fatty Liver Disease via Inhibition TRPM2 Ion Channel Activation
by: Feng Q, et al.
Published: (2019-12-01)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
by: Marta Borges-Canha, et al.
Published: (2020-10-01)

Properties and uses of some unsaturated fatty alcohols and their derivatives /
by: 346738 Egan, Richard R., et al.

Altered Fatty Acid Metabolism-Related Gene Expression in Liver from Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease
by: Teresa Auguet, et al.
Published: (2014-12-01)

Process for the production of saturated fatty alcohols /
by: 394427 Rittmeister, Wilhelm

Production, properties, and uses of fatty alcohols /
by: 333397 Hill, E. F., et al.

Continuous process of producing fatty alcohols /
by: 394629 Voeste, Theodor, et al.

Diagnostic accuracy of apoptosis markers in non-alcoholic fatty liver disease in children
by: Yu. M. Stepanov, et al.
Published: (2020-12-01)

The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
by: Hyunwoo Oh, et al.
Published: (2023-02-01)

Process for the production of fatty alcohols by catalytic hydrogenation of fatty acids and their derivatives /
by: 394609 Eisenlohr, Karl-Heinz, et al.

The Dietary Replacement of Soybean Oil by Canola Oil Does Not Prevent Liver Fatty Acid Accumulation and Liver Inflammation in Mice
by: Marina Masetto Antunes, et al.
Published: (2020-11-01)

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
by: Daryl Ramai, et al.
Published: (2021-12-01)

Assessment of interleukin 32 as a novel biomarker for non-alcoholic fatty liver disease
by: Manal Sabry Mohamed, et al.
Published: (2022-04-01)